Psychedelics PharmAla Biotech signs agreement to sell clinical-grade MDMA in Australia Companies are running more MDMA and psilocybin trials after the Australian drug regulation changes Natalia Buendia CalvilloFebruary 14, 2023
Psychedelics Psyched Wellness formulates first commercial Amanita muscaria extract The cartoon-like toadstool is psychoactive, has medicinal properties and lives in a symbiotic relationship with certain trees Rowan DunneFebruary 9, 2023
Psychedelics Optimi Health submits clinical trial application after developing proprietary MDMA drug The drug will be used to help establish a safe supply for patients in Canada and Australia Rowan DunneFebruary 7, 2023
Psychedelics Calgary’s ATMA launches psychedelic-assisted therapy training course for physicians The program's creation was inspired by new regulations for psychedelic-assisted therapy in Alberta Rowan DunneJanuary 27, 2023
Psychedelics New York legislators introduce bill to legalize natural psychedelics Bill A00114 would legalize adult possession and use of ibogaine, mescaline, psilocybin and psilocin Natalia Buendia CalvilloJanuary 3, 2023
Psychedelics Biomind Labs develops sublingual psychedelic drug to treat Alzheimer’s The under-the-tongue drug candidate will be studied in a Phase II clinical trial prior to commercialization Rowan DunneDecember 30, 2022
Psychedelics Colorado votes to decriminalize use and possession of natural psychedelics It also introduces state-regulated 'healing centers' where trained facilitators can offer psychedelic-assisted sessions Natalia Buendia CalvilloDecember 29, 2022
Psychedelics Non-profit launches supporting psychedelic traditions of Mexico’s Indigenous peoples Quetzalli will be collaborating with the Mexican charities Ha Ta Tukari and Reserva Natural Rancho Los Ocotes Rowan DunneDecember 22, 2022
Canada Health Canada provides guidance for clinical trials on psychedelics The notice to stakeholders outlined risk management and consent expectations for the study of psychoactive drugs Rowan DunneDecember 5, 2022
Cannabis U.S. senators introduce bill to improve access to psilocybin and MDMA The bill would reduce 'unreasonably burdensome rules and regulations' Rowan DunneNovember 23, 2022